John Samies, MD
Infectious Disease · Orangeburg, SCNPI 1801850128
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,743 of the $18,099 with a category attached, or 81.5%. Organogenesis Inc. accounts for 95.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $7,364 and has fallen 98.6% since, to $104 in 2025. Among infectious disease clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $223.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$17K
- Hydrofera LLC$170
- Smith+Nephew$160
- Medtronic$82
- Convatec Inc.$56
- Celularity Inc.$53
- plus $299 from 11 others
What the payments were for
- Speaking & faculty fees$14,74381%
- Travel & lodging$1,6629%
- Food & beverage$1,6949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 44 | $17,280 |
| Hydrofera LLC | 4 | $170 |
| Smith+Nephew | 9 | $160 |
| Medtronic | 1 | $82 |
| Convatec Inc. | 3 | $56 |
| Celularity Inc. | 1 | $53 |
| Merck | 3 | $42 |
| KCI USA, Inc. | 2 | $36 |
| Medela LLC | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Urgo Medical North America, LLC | 2 | $31 |
| Solventum Corporation | 1 | $26 |
| Next Science LLC | 3 | $26 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $20 |
| Advanced Oxygen Therapy Inc. | 1 | $19 |
| Misonix Inc | 1 | $17 |
| Molnlycke Health Care US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$9,382
- Apligraf$7,073
- Dermagraft$7,073
- Puraply/Affinity/NuTech$7,073
How this compares
$18,099 in reported general payments places this provider in the 90th percentile of 102 infectious disease providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CeftriaxoneCeftriaxone Sodium | 12 | $816 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Orangeburg
- Timothy HenkelHilton Head Island$1.8M
- Toby FugateCharleston$136K
- John McKinnonCharleston$85K
- John SchrankGreenville$74K
- Rishika MotianiFlorence$43K
- John GnannCharleston$39K
- Akinwale OlatosiCamden$17K
- Robert BallNorth Charleston$14K
- Eunice GuzmanMyrtle Beach$10K
- Scott CurryCharleston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.